Unternehmen Immunodiagnostic Systems Holdings PLC
Aktien
A0D9MS
GB00B01YZ052
IDH
Medizinische Versorgung
Kurzporträt
Mitarbeiterzahl: 276
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Jaap Stuut
CEO | Chief Executive Officer | 54 | 01.01.13 |
Gareth Dixon
DFI | Director of Finance/CFO | - | 01.01.22 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | - | 01.07.21 | |
Jaap Stuut
CEO | Chief Executive Officer | 54 | 01.01.13 |
Gareth Dixon
DFI | Director of Finance/CFO | - | 01.01.22 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 29 619 525 | 17 950 982 ( 60,61 %) | 666 078 ( 2,249 %) | 60,61 % |
Unternehmenskontakt
Immunodiagnostic Systems Holdings Ltd.
Boldon Business Park 10 Didcot Way
NE35 9PD, Boldon
+44 1915 190 660
http://www.idsplc.comKonzerngesellschaften
Name | Kategorie und Branche |
---|---|
Immunodiagnostic Systems Ltd.
Immunodiagnostic Systems Ltd. Department StoresRetail Trade Part of Revvity, Inc., Immunodiagnostic Systems Ltd. is a British company that manufactures and markets manual immunoassays and automated immunoanalyser technologies to improve diagnostic outcomes for patients. The private company is based in Boldon, UK. IDS also conducts research in other areas and offers hypertension immunoassays such as Renin assays and Aldosterone assays. The IDS about us section provides information on corporate history and strategic vision. The company was founded in 1995 by Robert William Cunningham. |
Department Stores
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+0,89 % | 12,8 Mrd. | |
-10,29 % | 7,61 Mrd. | |
+1,78 % | 5,41 Mrd. | |
-1,16 % | 4,51 Mrd. | |
+5,74 % | 4,49 Mrd. | |
-50,70 % | 3,29 Mrd. | |
+12,21 % | 2,73 Mrd. | |
-16,13 % | 2,02 Mrd. | |
-11,50 % | 1,73 Mrd. |